NCT04942717: Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients’ Health-Related Values

Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting

Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 21 Years and older (Adult, Older Adult)
Location of Metastases: 
Additional Notes: Patients must speak Spanish as their preferred language or are English-speaking and self identify as Latinx patients; Spanish-speaking family/other informal caregivers are also eligible to participate

Comments are closed.

Up ↑